Cargando…

Global Quality Standard for Identification and Management of Severe Asthma

INTRODUCTION: Severe asthma is a debilitating, life-threatening disease associated with substantial global morbidity, mortality, and health care resource utilization. Patients may not receive guideline-directed medical care for severe asthma. Moreover, viable precision-based assessment tools and new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haughney, John, Winders, Tonya A., Holmes, Steve, Chanez, Pascal, Saul, Hannah, Menzies-Gow, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444397/ https://www.ncbi.nlm.nih.gov/pubmed/32725419 http://dx.doi.org/10.1007/s12325-020-01450-7

Ejemplares similares

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
por: Haughney, John, et al.
Publicado: (2023)

A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

A Charter to Improve Patient Care in Severe Asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2018)

Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
por: Bhutani, Mohit, et al.
Publicado: (2022)

Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
por: Menzies-Gow, Andrew, et al.
Publicado: (2020)

Perspectives on decisions for treatment and care in severe asthma
por: Winders, Tonya, et al.
Publicado: (2021)

Defining severe asthma – an approach to find new therapies
por: Nanzer, Alexandra M., et al.
Publicado: (2014)

A Patient-Centered Description of Severe Asthma: Patient Understanding Leading to Assessment for a Severe Asthma Referral (PULSAR)
por: Winders, Tonya A., et al.
Publicado: (2019)

Is it severe asthma or asthma with severe comorbidities?
por: Brussino, Luisa, et al.
Publicado: (2017)

Identifying Patients for Self-Administration of Omalizumab
por: Murphy, Kevin R., et al.
Publicado: (2022)

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial
por: Crim, Courtney, et al.
Publicado: (2022)

Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary—Child (PAD-C) and Pediatric Asthma Diary—Observer (PAD-O)
por: Bradley, Helena, et al.
Publicado: (2023)

Benefits of specialist severe asthma management: demographic and geographic disparities
por: Redmond, Charlene, et al.
Publicado: (2022)

A Patient Charter for Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2020)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age
por: Kaplan, Alan G., et al.
Publicado: (2021)

Asthma: still a promising future?
por: Chanez, Pascal, et al.
Publicado: (2014)

The Biology of Eosinophils and Their Role in Asthma
por: McBrien, Claire N., et al.
Publicado: (2017)

Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Menzies-Gow, Andrew, et al.
Publicado: (2017)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Long‐term corticosteroid use, adrenal insufficiency and the need for steroid‐sparing treatment in adult severe asthma
por: Gurnell, M., et al.
Publicado: (2021)

Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
por: Haughney, John, et al.
Publicado: (2023)

Identification and management of adults with asthma prone to exacerbations: can we do better?
por: Thomson, Neil C, et al.
Publicado: (2008)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

Simulation-Based Mastery Learning With Virtual Coaching: Experience in Training Standardized Upper Endoscopy to Novice Endoscopists
por: Soetikno, Roy, et al.
Publicado: (2020)

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013)

Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry
por: Sweeney, Joan, et al.
Publicado: (2012)

Standardizing metadata and taxonomic identification in metabarcoding studies
por: Tedersoo, Leho, et al.
Publicado: (2015)

Holy Grail: the journey towards disease modification in asthma
por: Busse, William W., et al.
Publicado: (2022)

Frequent exacerbators in severe asthma: Focus on clinical and transcriptional factors
por: Thomson, Neil C.
Publicado: (2022)

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
por: Langley, Paul C
Publicado: (2022)

Real-world use and perceptions of shared decision-making for allergy and asthma care in a US population
por: Eghrari-Sabet, Jacqueline, et al.
Publicado: (2023)

The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem
por: Kaplan, Alan
Publicado: (2021)

Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma
por: Hanania, Nicola A., et al.
Publicado: (2022)

Targeting TSLP in Asthma
por: Parnes, Jane R, et al.
Publicado: (2022)

Bacteria in sputum of stable severe asthma and increased airway wall thickness
por: Zhang, Qingling, et al.
Publicado: (2012)

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma
por: Bleecker, Eugene R., et al.
Publicado: (2018)

Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
por: Heatley, Heath, et al.
Publicado: (2023)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

The role of reporting standards for metabolite annotation and identification in metabolomic studies
por: Salek, Reza M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rfeunk3c4rao4vhjitnsft7g1p